Skip to content

Analysis of chemotherapy induced-food preference alternation

Analysis of chemotherapy induced-food preference alternation - CHEF-PAL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000013619
Enrollment
100
Registered
2014-04-04
Start date
2014-04-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with solid tumor and hematologic malignancy who receive chemotherapy

Interventions

None listed

Sponsors

Oita University Faculty Of Medicine Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) patients with unresectable solid tumor and hematologic malignancy who receive chemotherapy 2) no prior chemotherapy / no radiation therapy 3) adequate use of antiemetics based on the Japanese Clinical Practice Guidelines 4) age 20 or over 5) The Eastern Cooperative Oncology Group(ECOG) Performance Status: 0~2 6) preserved organ functions 7) estimated prognosis >= 3 months 8) written informed consent was obtained

Exclusion criteria

Exclusion criteria: 1) dysfunction of food intake and mastication 2) alimentary tract obstruction 3) prior local irradiation from oral cavity to esophagus 4) severe diabetes mellitus 5) uncontrolled non-malignant digestive diseases 6) other unacceptable reasons

Design outcomes

Primary

MeasureTime frame
Identification of food preference alternation following chemotherapy

Countries

Japan

Contacts

Public ContactKoichiro Watanabe

Oita University Faculty Of Medicine Graduate School of Medicine Department of Medical Oncology & Hematology

kwata@oita-u.ac.jp097-549-4411

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026